5-Nitrosalicylic acid → N-{3,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-nitrobenzamide

HRID 421151

Reaktionsgleichung

Reaktionsgleichung von HRID 421151
[N+:1]([C:4]1[CH:12]=[C:8]([C:9]([OH:11])=O)[C:7]([OH:13])=[CH:6][CH:5]=1)([O-:3])=[O:2].[CH3:14][C:15]([C:18]1[CH:19]=[C:20]([CH:22]=[C:23]([C:25]([CH3:28])([CH3:27])[CH3:26])[CH:24]=1)[NH2:21])([CH3:17])[CH3:16]>>[CH3:17][C:15]([C:18]1[CH:19]=[C:20]([NH:21][C:9](=[O:11])[C:8]2[CH:12]=[C:4]([N+:1]([O-:3])=[O:2])[CH:5]=[CH:6][C:7]=2[OH:13])[CH:22]=[C:23]([C:25]([CH3:28])([CH3:27])[CH3:26])[CH:24]=1)([CH3:14])[CH3:16]

Komponenten

3

Versuchsvorschrift

Using 5-nitrosalicylic acid and 3,5-bis[(1,1-dimethyl)ethyl]aniline as the raw materials, the same operation as the example 16 gave the title compound.

Quellen und Nachweise

ORD-Eintrag
ord-4f583a0238b8467092237426cd919b1a
Quelldatensatz
uspto-grants-2012_01
Patentnummer
US08097759B2

Verknüpfte Notizen

Wird geladen…